Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun Fan

Showing results (1-10 of 1,024) with videos related to

Pageof 103
Sort By:
Hepatology (Baltimore, Md.)|October 6, 2020
Reply to Letter to the Editor: Retreatment Decision for Hepatitis B FlareYun-Fan Liaw
Clinical and Molecular Hepatology|January 31, 2024
Letter regarding "Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation"Yun-Fan Liaw
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Impact of hepatitis B therapy on the long-term outcome of liver diseaseYun-Fan Liaw
Hepatology (Baltimore, Md.)|April 20, 2011
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a reviewYun-Fan Liaw
Journal of Gastroenterology and Hepatology|January 12, 2005
Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis BYun-Fan Liaw
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Impact of therapy on the outcome of chronic hepatitis BYun-Fan Liaw
Journal of Gastroenterology and Hepatology|May 2, 2002
Management of patients with chronic hepatitis BYun-Fan Liaw
The Journal of Infectious Diseases|July 9, 2018
Immune Responses and Hepatitis B Surface Antigen Loss After Cessation of Direct Antiviral Therapy in Hepatitis B e Antigen-Negative PatientsYun-Fan Liaw
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Natural history of chronic hepatitis B virus infection and long-term outcome under treatmentYun-Fan Liaw
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 24, 2020
Undesirable Long-Term Outcome of Entecavir Therapy in Chronic Hepatitis B With CirrhosisYun-Fan Liaw
Pageof 103

Showing results (1-10 of 1,024) with videos related to

Sort By:
Pageof 103
Hepatology (Baltimore, Md.)|October 6, 2020
Reply to Letter to the Editor: Retreatment Decision for Hepatitis B FlareYun-Fan Liaw
Clinical and Molecular Hepatology|January 31, 2024
Letter regarding "Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation"Yun-Fan Liaw
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Impact of hepatitis B therapy on the long-term outcome of liver diseaseYun-Fan Liaw
Hepatology (Baltimore, Md.)|April 20, 2011
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a reviewYun-Fan Liaw
Journal of Gastroenterology and Hepatology|January 12, 2005
Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis BYun-Fan Liaw
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Impact of therapy on the outcome of chronic hepatitis BYun-Fan Liaw
Journal of Gastroenterology and Hepatology|May 2, 2002
Management of patients with chronic hepatitis BYun-Fan Liaw
The Journal of Infectious Diseases|July 9, 2018
Immune Responses and Hepatitis B Surface Antigen Loss After Cessation of Direct Antiviral Therapy in Hepatitis B e Antigen-Negative PatientsYun-Fan Liaw
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Natural history of chronic hepatitis B virus infection and long-term outcome under treatmentYun-Fan Liaw
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 24, 2020
Undesirable Long-Term Outcome of Entecavir Therapy in Chronic Hepatitis B With CirrhosisYun-Fan Liaw
Pageof 103